CD274 and hepatocellular carcinoma: Nowadays, the emergence of immune checkpoint inhibitors (ICIs), represented by Programmed death receptor-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) inhibitors, has brought revolutionary breakthroughs in the treatment of advanced HCC (11).